Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells
- 1 December 2008
- journal article
- Published by Wiley in Immunology
- Vol. 125 (4), 469-479
- https://doi.org/10.1111/j.1365-2567.2008.02860.x
Abstract
Dendritic cells (DCs) play a key role in the type and course of an immune response. The manipulation of human DCs to produce therapeutic agents by transduction with viral vectors is a growing area of research. We present an investigation into the effects of adenoviral vector infection on human DCs and other cell types, and on their subsequent ability to induce T-cell proliferation. We show that infection with replication-deficient adenovirus results in impaired proliferation of T cells in a mixed lymphocyte reaction (MLR). We show this to be an active suppression rather than a defect in the DCs as T cells also fail to proliferate in response to phytohaemagglutinin in the presence of adenoviral vector-infected DCs. This suppression is not attributable to phenotypic changes, death or inability of the DCs to produce cytokines on stimulation. By separation of DCs from T cells, and addition of conditioned supernatants, we show that suppression is mediated by a soluble factor. Blocking of interleukin (IL)-10 but not transforming growth factor (TGF)-beta could overcome the suppressive effect in some donors, and the source of the suppressive IL-10 was lymphocytes exposed to conditioned supernatant. Together our data suggest that infection of DCs by adenoviral vectors leads to suppression of the resulting immune response.Keywords
This publication has 36 references indexed in Scilit:
- Brn-3a neuronal transcription factor functional expression in human prostate cancerProstate Cancer and Prostatic Diseases, 2005
- Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10—producing CD4+ T cellsHuman Immunology, 2004
- Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapyGene Therapy, 2004
- Modified adenoviruses for cancer gene therapyInternational Journal of Cancer, 2004
- Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteinsThe Journal of Gene Medicine, 2004
- Induction of regulatory dendritic cells by dexamethasone and 1α,25-Dihydroxyvitamin D3Immunology Letters, 2004
- In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing CytokinesThe Journal of Experimental Medicine, 2002
- Expression profiles of voltage‐gated Na+ channel α‐subunit genes in rat and human prostate cancer cell linesThe Prostate, 2001
- Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacityGene Therapy, 2000
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994